Neurocrine Biosciences is a corporate venture arm. Based in San Diego, California, United States. Among the 2 companies in the known portfolio are Voyager Therapeutics and Xenon Pharmaceuticals.
Is Neurocrine Biosciences a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
- Sector
- Healthcare
Contacts
Neurocrine Biosciences portfolio companies (2)
- Voyager Therapeutics
- Xenon Pharmaceuticals
Co-investors
Funds that share portfolio companies with Neurocrine Biosciences.
Similar funds
Showing 20 of 100
About Neurocrine Biosciences
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Genomics and Pharma; known deals cluster at Late-Stage.
Across the known portfolio, one co-investor appears alongside Neurocrine Biosciences: Invesco.
Frequently asked questions
What is Neurocrine Biosciences?
Neurocrine Biosciences is a corporate venture arm based in San Diego, California, United States, with a known portfolio of 2 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Neurocrine Biosciences invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Genomics and Pharma. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Neurocrine Biosciences invest at?
The known deals of Neurocrine Biosciences include Late-Stage rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Neurocrine Biosciences?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal